Repository logo
Communities & Collections
All of DSpace
  • English
  • العربية
  • বাংলা
  • Català
  • Čeština
  • Deutsch
  • Ελληνικά
  • Español
  • Suomi
  • Français
  • Gàidhlig
  • हिंदी
  • Magyar
  • Italiano
  • Қазақ
  • Latviešu
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Српски
  • Svenska
  • Türkçe
  • Yкраї́нська
  • Tiếng Việt
Log In
New user? Click here to register. Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Robles Sanmartin, Javier"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Publication
    Limb-sparing surgery using the new ITC spanish porous titanium endoprosthesis in a dog with distal radius osteosarcoma
    (WVOC-ESVOT, 2018) Jiménez Socorro, Antonio Nicolás; Martín, Afonso; Bernardi Villavicencio, Cristina; Jiménez Heras, Maria; Rojo Salvador, Concepción; Robles Sanmartin, Javier; Rodríguez Quirós, Jesús; Jiménez Socorro, Antonio Nicolás
    Osteosarcoma (OSA) is the most common bone tumour in Dogs and in giant breeds it’s commonly located in distal radius. Treatment includes: surgery (limb amputation or limb-sparing surgery), radiotherapy and chemotherapy. Amputation is a first-line procedure, it increases survival, brings pain relief thereby delays euthanasia. But limb amputation in giant breeds decreases life quality so limb-sparing surgery can be considered as a good option of treatment. New porous titanium developed by Instituto Tecnológico de Canarias (ITC) can be use as bone substitute in combination with a stabilized plate It has been described that titanium endoprosthesis with limb salvage does not affect survival and provides some advantages over traditional amputation, for OSA treatment.1,3,4 Premature resection of distal radius osteosarcoma and implantation of ITC porous titanium endoprosthesis can be an acceptable option of treatment for the distal radius OSA in dogs, as it increases a quickly return to normal limb function and life quality.
  • Loading...
    Thumbnail Image
    Publication
    Short-term outcomes and complications of 65 cases of porous TTA with flange: a prospective clinical study in dogs
    (2020) Bernardi Villavicencio, Cristina; Jiménez Socorro, Antonio Nicolás; Rojo Salvador, Concepción; Robles Sanmartin, Javier; Rodríguez Quirós, Jesús
    Background: Cranial cruciate ligament rupture (CrCLR) is the most common orthopaedic cause of lameness in the hind limb in dogs. Many surgical treatments have been described, but tibial tuberosity advancement (TTA) is one of the most commonly used today. Since it was first described, TTA has evolved to reduce major complications and to arrest the progression of osteoarthrosis. The aim of this study was to assess a surgical technique called Porous TTA with flange prospectively. This study was performed in 61 dogs that underwent 65 Porous TTA with flange procedures, to validate it as an alternative CrCLR treatment. Complications and clinical outcomes (pain, lameness, weight bearing, flexion, extension, crepitation and atrophy) were reported over 3 months, i.e. at 3, 6 and 12 weeks postoperatively. Results: The results showed a positive clinical outcome, a minor complication rate of 47.69% at the first review 3 weeks postoperatively, 10.77% at the second one (6 weeks after the surgery) and 4% at the third one (at 12 weeks). Major complications were observed only at the last review, with one case that had an infection requiring implant removal; this represented 1.5% of cases. Variables evaluated for a relationship with complication scores and improvement were body condition score, sex, age, breed, body weight, breed size, side of the affected limb, traumatic anamnesis and time of lameness before surgery. No relationship was detected. Conclusions: Clinical outcomes and complications show that Porous TTA with flange is an efficient alternative for surgical treatment of CrCLR in dogs.

DSpace software copyright © 2002-2026 LYRASIS

  • Privacy policy
  • End User Agreement
  • Send Feedback